Advertisement

Advertisement

HK:0950 Stock Latest News

Lee’s Pharmaceutical launches HK$50 million share buyback programme

Company AnnouncementsLee’s Pharmaceutical launches HK$50 million share buyback programme

Lee’s Pharm Wins Gates Foundation Funding for Infant Respiratory Drug Push

PremiumCompany Announcements

Lee’s Pharm Wins Gates Foundation Funding for Infant Respiratory Drug Push

1M ago

Lee’s Pharmaceutical Wins Strong Shareholder Backing for Dividend, Board and Share Mandates at AGM

PremiumCompany Announcements

Lee’s Pharmaceutical Wins Strong Shareholder Backing for Dividend, Board and Share Mandates at AGM

1M ago

Lee’s Pharma commits RMB25m to connected biotech partnership fund

PremiumCompany Announcements

Lee’s Pharma commits RMB25m to connected biotech partnership fund

2M ago

Lee’s Pharmaceutical Sets 2026 AGM to Approve Results, Dividend and Capital Mandates

PremiumCompany Announcements

Lee’s Pharmaceutical Sets 2026 AGM to Approve Results, Dividend and Capital Mandates

2M ago

Lee’s Pharmaceutical Declares Final Dividend for 2025

PremiumCompany AnnouncementsLee’s Pharmaceutical Declares Final Dividend for 2025

3M ago

Lee’s Pharmaceutical posts flat profit on higher costs, trims final dividend

Company Announcements

Lee’s Pharmaceutical posts flat profit on higher costs, trims final dividend

3M ago

Lee’s Pharm Wins China Approval for Intrarosa, Bolstering Women’s Health Portfolio

Company Announcements

Lee’s Pharm Wins China Approval for Intrarosa, Bolstering Women’s Health Portfolio

3M ago

Lee’s Pharmaceutical Sets March 2026 Board Meeting to Review 2025 Results

PremiumCompany Announcements

Lee’s Pharmaceutical Sets March 2026 Board Meeting to Review 2025 Results

4M ago

Lee’s Pharm Wins FDA Clearance for U.S. ADASUVE Manufacturing Shift

PremiumCompany Announcements

Lee’s Pharm Wins FDA Clearance for U.S. ADASUVE Manufacturing Shift

5M ago

Lee’s Pharma Adds Financial Detail to Discloseable Asset Acquisition

PremiumCompany Announcements

Lee’s Pharma Adds Financial Detail to Discloseable Asset Acquisition

7M ago

Lee’s Pharmaceutical Mourns Death of Senior Business Development Director Michele Dalla Libera

PremiumCompany Announcements

Lee’s Pharmaceutical Mourns Death of Senior Business Development Director Michele Dalla Libera

7M ago

Lee’s Pharmaceutical Acquires Alexza Business Assets for $15 Million

PremiumCompany AnnouncementsLee’s Pharmaceutical Acquires Alexza Business Assets for $15 Million

7M ago

Lee’s Pharmaceutical Advances Pain Management with Inhaled Fentanyl Study

Company Announcements

Lee’s Pharmaceutical Advances Pain Management with Inhaled Fentanyl Study

8M ago

Lee’s Pharmaceutical Advances AU409 Study in Hepatocellular Carcinoma

Company Announcements

Lee’s Pharmaceutical Advances AU409 Study in Hepatocellular Carcinoma

8M ago

Lee’s Pharmaceutical Advances Neonatal Care with New Clinical Study

PremiumCompany Announcements

Lee’s Pharmaceutical Advances Neonatal Care with New Clinical Study

8M ago

Lee’s Pharmaceutical Advances in Cervical Cancer Treatment: A Phase III Study Update

PremiumCompany Announcements

Lee’s Pharmaceutical Advances in Cervical Cancer Treatment: A Phase III Study Update

8M ago

Lee’s Pharmaceutical Advances in Glioma Surgery: A Phase III Trial Update

PremiumCompany Announcements

Lee’s Pharmaceutical Advances in Glioma Surgery: A Phase III Trial Update

8M ago

Lee’s Pharmaceutical Grants Share Options to Boost Engagement

PremiumCompany Announcements

Lee’s Pharmaceutical Grants Share Options to Boost Engagement

9M ago

Lee’s Pharmaceutical Enhances Governance with New Nomination Committee

PremiumCompany AnnouncementsLee’s Pharmaceutical Enhances Governance with New Nomination Committee

10M ago

Lee’s Pharmaceutical Announces Interim Dividend for First Half of 2025

Company Announcements

Lee’s Pharmaceutical Announces Interim Dividend for First Half of 2025

10M ago

Lee’s Pharmaceutical Reports Revenue Growth Amid Strategic Product Diversification

Company Announcements

Lee’s Pharmaceutical Reports Revenue Growth Amid Strategic Product Diversification

10M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >